Cite
HARVARD Citation
Wu, S. et al. (2021). Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet infectious diseases. 21 (12), pp. 1654-1664. [Online].